Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer
Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer: a Prospective Randomized Control Trial.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
170 participants
Feb 17, 2023
INTERVENTIONAL
Conditions
Summary
The standard method for localizing non-palpable breast cancer is currently preoperative wire-guided localization, its positive margin rate still remains around 20-50%. This study aims to compare the accuracy and efficacy of wire vs. combined breast tissue markers in localizing non-palpable breast cancer.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Positioning guide wire and marker clip in the center of the lesion
Positioning guide wire in the center of the lesion
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05797454